Zeo ScientifiX Files 8-K
Ticker: ZEOX · Form: 8-K · Filed: Oct 23, 2025 · CIK: 1557376
Sentiment: neutral
Topics: 8-K, corporate-filing, biological-products
TL;DR
Zeo ScientifiX filed an 8-K on 10/23/25. Nothing major disclosed yet.
AI Summary
Zeo ScientifiX, Inc. filed an 8-K on October 23, 2025, reporting other events and financial statements. The company, formerly known as Organicell Regenerative Medicine, Inc., is incorporated in Nevada and operates in the biological products sector.
Why It Matters
This filing indicates routine corporate reporting, potentially including updates on financial status or significant business events for Zeo ScientifiX, Inc.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for other events and exhibits, not indicating any immediate material adverse changes.
Key Numbers
- 000-55008 — SEC File Number (Identifies the company's filing with the SEC.)
- 47-4180540 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Zeo ScientifiX, Inc. (company) — Registrant
- Organicell Regenerative Medicine, Inc. (company) — Former company name
- October 23, 2025 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- 3321 College Avenue, Suite 246 Davie, Florida 33314 (address) — Business address
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text does not detail the specific 'Other Events' reported, only that this item is included in the filing.
What is the primary business of Zeo ScientifiX, Inc.?
Zeo ScientifiX, Inc. operates in the 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' sector, SIC code 2836.
When was Zeo ScientifiX, Inc. previously known by another name?
Zeo ScientifiX, Inc. was formerly known as Organicell Regenerative Medicine, Inc., with a name change date of June 25, 2018.
Where is Zeo ScientifiX, Inc. incorporated and headquartered?
The company is incorporated in Nevada and its business address is located in Davie, Florida.
What is the significance of the filing date of October 23, 2025?
October 23, 2025, is the date of the earliest event reported in this 8-K filing.
Filing Stats: 484 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-10-23 08:30:32
Filing Documents
- zeoscientifix_8k.htm (8-K) — 26KB
- zeoscientifix_ex99-1.htm (EX-99.1) — 15KB
- 0001829126-25-008357.txt ( ) — 202KB
- ocel-20251023.xsd (EX-101.SCH) — 3KB
- ocel-20251023_lab.xml (EX-101.LAB) — 33KB
- ocel-20251023_pre.xml (EX-101.PRE) — 22KB
- zeoscientifix_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On October 23, 2025 ZEO issued a press release announcing that the Company is prepared to capitalize on the potentially rapid expansion of Florida's regenerative medicine market following enactment of the new state stem cell law, SB 1768, effective July 1, 2025. A copy of the press release is included as Exhibit 99.1 to this Report and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated October 23, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 23, 2025 ZEO SCIENTIFIX, INC. By: /s/ Ian T. Bothwell Ian T. Bothwell Interim Chief Executive Officer and Chief Financial Officer 2